Literature DB >> 27129710

Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort.

Hua Ye1, Yin Su2, Ru Li1, Jinxia Zhao3, Xiangyuan Liu3, Yifang Mei4, Zhiyi Zhang4, Jialong Guo5, Liqi Bi5, Xia Liu6, Guochun Wang6, Jinjing Liu7, Xiaomei Leng7, Fei Gu8, Lingyun Sun8, Qinghua Zou9, Yongfei Fang9, Quan Jiang10, Zhanguo Li11.   

Abstract

The aim of this study is to compare the three classification criteria for rheumatoid arthritis (RA) in a large cohort of early arthritis patients. Patients who had at least one clinically swollen joint with disease duration no more than 1 year and age more than 18 years were enrolled. The clinical and laboratory parameters were recorded. The patients were diagnosed by two experienced rheumatologists. Undiagnosed patients were followed up every 3 months until 1 year. The sensitivity, specificity, and predictive value were compared among the early RA (ERA) criteria, the 1987 ACR criteria, and the 2010 ACR/EULAR criteria in this inception cohort of early arthritis patients. A total of 417 patients with inflammatory arthritis were recruited. By the end of 1 year follow-up, there were 399 patients (95.7 %) with a definitive diagnosis and 18 (4.3 %) patients remained as undifferentiated arthritis. Among the patients with definitive diagnosis, 202 (50.6 %) patients were diagnosed with RA and 197 (49.4 %) with non-RA. The sensitivity of ERA criteria was equal to 2010 ACR/EULAR criteria (both were 72.3 %), but much higher than 1987 ACR criteria (72.3 vs. 39.1 %, P < 0.001); the specificity of ERA criteria was comparable to 2010 ACR/EULAR criteria (87.8 vs. 83.2 %) and slightly lower than 1987 ACR criteria (87.8 vs. 92.4 %, P < 0.001). Unlike the complicated scoring system of 2010 criteria, the ERA criteria were more feasible to use in practice with five criteria only. The ERA criteria have a high sensitivity and more clinically feasibility in daily practice for early RA diagnosis.

Entities:  

Keywords:  Arthritis; Classification criteria; Early; Rheumatoid

Mesh:

Year:  2016        PMID: 27129710     DOI: 10.1007/s10067-016-3281-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.

Authors:  L R Lard; H Visser; I Speyer; I E vander Horst-Bruinsma; A H Zwinderman; F C Breedveld; J M Hazes
Journal:  Am J Med       Date:  2001-10-15       Impact factor: 4.965

2.  Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort.

Authors:  Mohammed Z Cader; Andrew Filer; Jonathan Hazlehurst; Paola de Pablo; Christopher D Buckley; Karim Raza
Journal:  Ann Rheum Dis       Date:  2011-02-01       Impact factor: 19.103

3.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

4.  Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria.

Authors:  Yuko Kaneko; Masataka Kuwana; Hideto Kameda; Tsutomu Takeuchi
Journal:  Rheumatology (Oxford)       Date:  2011-02-03       Impact factor: 7.580

5.  Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later.

Authors:  A Saraux; J M Berthelot; G Chalès; C Le Henaff; J B Thorel; S Hoang; I Valls; V Devauchelle; A Martin; D Baron; Y Pennec; E Botton; J Y Mary; P Le Goff; P Youinou
Journal:  Arthritis Rheum       Date:  2001-11

6.  Comparison of the 1987 ACR criteria and the 2010 ACR/EULAR criteria in an inception cohort of patients with recent-onset inflammatory polyarthritis.

Authors:  S Reneses; L Pestana; A Garcia
Journal:  Clin Exp Rheumatol       Date:  2012-06-26       Impact factor: 4.473

7.  Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria.

Authors:  M P M van der Linden; R Knevel; T W J Huizinga; A H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2011-01

8.  Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New Zealand.

Authors:  Rafi Raja; Peter T Chapman; John L O'Donnell; Jan Ipenburg; Chris Frampton; Miriam Hurst; Lisa K Stamp
Journal:  J Rheumatol       Date:  2012-09-15       Impact factor: 4.666

9.  Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care.

Authors:  Lauren Kennish; Monalyn Labitigan; Sam Budoff; Maria T Filopoulos; W Andrew McCracken; Christopher J Swearingen; Yusuf Yazici
Journal:  BMJ Open       Date:  2012-10-03       Impact factor: 2.692

10.  Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort.

Authors:  Iuliia Biliavska; Tanja A Stamm; Jose Martinez-Avila; Thomas W J Huizinga; Robert B M Landewé; Günter Steiner; Daniel Aletaha; Josef S Smolen; Klaus P Machold
Journal:  Ann Rheum Dis       Date:  2012-09-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.